echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The latest base drug conference seven information, 349 exclusive specifications of the base drug to fire?

    The latest base drug conference seven information, 349 exclusive specifications of the base drug to fire?

    • Last Update: 2020-07-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: The contents of the latest basic drug conference seven major information outflow!----, the health care bureau-led national mining, belt harvesting, medical insurance, state talk is in full swing;the latest meeting content of a "base medicine" the latest basic drug meeting content of the seven major information outflow, the first: 2020 first out of the "base drug management measures", on the basis of the 2015 edition of the revision; Article 2 of the: "The Measures for the Administration of Base Medicines" will formulate a specific base drug adjustment plan after the introduction, and the preliminary provisional 2020 years will not adjust the base drug catalogue (685)Article 3 of the: The adjustment cycle of the Base Drug Catalog remains unchanged for three years and may be adjusted appropriately in the futureArticle 4: The positioning of the base drug does not change, or in accordance with the requirements of "Base Drug System No88"; article 5 of the: The meeting did not mention the requirement of 1 plus xArticle 6: It is recommended that the base drug be combined with the long prescription policy for chronic diseases, and the state has designed from the top level to develop a catalogue of the core drug use of the base drugArticle 7 of the: Comprehensive clinical evaluation, encourage trade associations, scientific research institutions, production enterprises, medical institutions, social organizations, etcto actively carry out evidence-based medical research, clinical medical evaluation (based drug consistent evaluation? )。feng yun summary review: 1, catalog temporarily do not move: according to the spirit of the meeting can know that the new "base medicine catalog" should not be published before the end of 2020, then, 2021 (2018-2019-2020-2021) has reached a three-year cycle, 2021 out of the "base medicine catalog" should be relatively stable2, the process is not determined: although this meeting information said that the base drug catalog to determine the relevant process, experts, methods are not determined, but the basic work of the base medicine catalog has been prepared, from the enterprises actively prepare for the "next round of base medicine catalog" can be seen;3, encourage the evaluation of the base drug? : On the current "national harvest" big policyfrom the point of view of enterprises and sales for small varieties of evaluation is really not attractive, market share of large enterprises are not temporarily but the evaluation may be better, at least can mix a "food and drink"; can be seen in the third batch of 27 metformin tablet manufacturers large PK, this PK selection and not the difference is the amount of good-looking price, fight for a future price increase opportunities how many enterprises were "tortured" by the 289 catalogue to die, banknotes spent thousands of dollars, after winning the bid to earn a "drinking" 4, Base Medicine 9.8.6: Here's a simple logic, start-up and don't start? The new catalog of the base drug was introduced at the beginning of the start of the base drug 9.8.6 so, each measure the new "base medicine catalog" is introduced is happy or sad? Once the base drug 9.8.6 started, the hospital kicks the variety, adjusts the product structure, the exclusive base drug starts the fire, there is space for the health insurance base medicine is on fire -based drug 9.8.6 plus DRG: the hospital will usher in the largest in the history of "in-hospital products", no efficacy of the varieties will be completely played 5, exclusive Chinese medicine: look at the exclusive base medicine products, exclusive specifications of Chinese medicine is really much ah, there is an exclusive Chinese medicine-based medicine approval of small partners, quickly wake up, health and health committee issued "red envelopes." two "685 base medicine" exclusive rules we all know, Fengyun medicine talk has always been "to take people", today is no exception, pulled up half a day of meeting content, estimated comrades look trapped, some comrades are very excited, some comrades do not care, some comrades do not know what to do below on 685 "base medicine catalog" exclusive (spec) products to do this display for everyone; : 134 exclusive chinese medicine: 215 exclusive rules exclusive basic drug regulation product details (source: base medicine catalog Fengyun drug talk exclusive finishing point)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.